3 December 2021 - The International Coalition of Medicines Regulatory Authorities and the World Health Organisation have reviewed some of the practices applied by regulatory authorities worldwide to respond to the challenges faced during the COVID-19 pandemic.
In the context of COVID-19, regulatory authorities have adapted some of their regulatory frameworks and streamlined their procedures while ensuring a high level of quality, safety and efficacy of the medicinal products made available to patients around the world.